Sustaining treatment costs: who will pay?
Scaling up antiretroviral treatment in resource-limited settings: successes and challenges
Combining prevention, treatment and care: lessons from South Africa
Sustaining access to antiretroviral therapy in the less-developed world: lessons from Brazil and Thailand
Treatment at scale in Brazil: a physician's perspective
Brazilian policy of universal access to AIDS treatment: sustainability challenges and perspectives
Predictors of failure of first-line antiretroviral therapy in HIV-infected adults: Indian experience
Second-line combination antiretroviral therapy in resource-limited settings: facing the challenges through clinical research
Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV
Antiretroviral drug development: the challenge of cost and access
Access to diagnostics in support of HIV/AIDS and tuberculosis treatment in developing countries
Use of antiretroviral therapy in resource-limited countries in 2006: distribution and uptake of first- and second-line regimens
Forecast of demand for antiretroviral drugs in low and middle-income countries: 2007–2008
The economics of effective AIDS treatment in Thailand
Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy
Comment on Ford et al., ‘Sustaining access to antiretroviral therapy in developing countries: lessons from Brazil and Thailand’
Response to Abbott: Governments, not companies, must be able to decide what is an affordable price